Samuel Murray

EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer.

I. Dahabreh, H. Linardou, D. Bafaloukos, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small-cell lung cancer: clinical and molecular considerations.

C. Papadimitriou, H. Linardou, D. Bafaloukos, 2011, Current medicinal chemistry.

Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients.

G. Fountzilas, D. Pectasides, H. Linardou, 2006, Lung cancer.

Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies.

C. Papadimitriou, H. Linardou, D. Bafaloukos, 2012, Cancer treatment reviews.